Greenland appointed its first Arctic ambassador on Friday, pledging to promote sustainable economic development for ...

European Commission President Ursula von der Leyen held a call with metals industry representatives on Monday and was due to ...

European pharma companies warned the European Commission president at a meeting on Tuesday that US tariffs wou ...

Denmark’s economy was reshaped by Novo Nordisk and obesity drugs. That identity is now under attack on multiple fronts, from ...

Novo Nordisk (NVO), the company behind Ozempic and Wegovy, announced that it will invest 6.4 billion reais (about $1.09 billion) in Brazil to increase production at its facility in Minas Gerais.

Novo Nordisk has reported the second phase 3 trial of its new obesity hopeful CagriSema but, as with the first, the topline weight-loss result has sent its shares into a sharp decline. The stock ...

Novo Nordisk has filed another Citizen's Petition with the FDA seeking to block compounding pharmacies in the US from making versions of one of its GLP-1 agonist drugs. The latest attempt focuses ...

A gradual drip feed of investment into a diverse range of quality companies could be a smart approach, Nick Saunders ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...